If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Shuji Mikami is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Renal Cell Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Kidney Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Urinary Bladder Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 2659 Citations
  • 27 h-Index
  • 140 Article
  • 1 Chapter
  • 1 Review article

Clinical significance of programmed death-1 and programmed death-ligand 1 expression in the tumor microenvironment of clear cell renal cell carcinoma

the Japanese Society of Renal Cancer, 2019 Jun 1, In : Cancer science. 110, 6, p. 1820-1828 9 p.

Research output: Contribution to journalArticle

Open Access
Tumor Microenvironment
Renal Cell Carcinoma
Ligands
Neoplasms
Protein-Tyrosine Kinases
1 Citation (Scopus)

Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma

Ito, K., Masunaga, A., Tanaka, N., Mizuno, R., Shirotake, S., Yasumizu, Y., Ito, Y., Miyazaki, Y., Hagiwara, M., Kanao, K., Mikami, S., Momma, T., Masuda, T., Nakagawa, K., Oyama, M., Asano, T. & Oya, M., 2019 Jan 1, In : Japanese Journal of Clinical Oncology. 49, 1, p. 69-76 8 p.

Research output: Contribution to journalArticle

Disease-Free Survival
L-Lactate Dehydrogenase
Neutrophils
Lymphocytes
Therapeutics
Allelic Imbalance
Platinum
Prostatic Neoplasms
Mutation
Therapeutics
1 Citation (Scopus)
Renal Cell Carcinoma
C-Reactive Protein
Blood Proteins
Therapeutics
Molecular Targeted Therapy

Sulfasalazine could modulate the CD44v9-xCT system and enhance cisplatin-induced cytotoxic effects in metastatic bladder cancer

Ogihara, K., Kikuchi, E., Okazaki, S., Hagiwara, M., Takeda, T., Matsumoto, K., Kosaka, T., Mikami, S., Saya, H. & Oya, M., 2019 Apr 1, In : Cancer Science. 110, 4, p. 1431-1441 11 p.

Research output: Contribution to journalArticle

Open Access
Sulfasalazine
Urinary Bladder Neoplasms
Cisplatin
p38 Mitogen-Activated Protein Kinases
Muscles